FDA Advisory Committee To Review Amgen's Talimogene Laherparepvec
February 11, 2015 at 16:23 PM EST
Amgen (NASDAQ: AMGN) announced today that the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) and the Oncologic Drugs ...